KOPRAN
|
The Current P/E Ratio of KOPRAN is 22.48.
Share Price | ₹179.4 | Jul 15,2025 |
Market Cap | ₹866.5 Cr | |
Earnings-TTM | ₹38.6 Cr | TTM-Consolidated Results |
Price/Earnings | 22.48x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of KOPRAN
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹866.5 Cr] as on Jul 15,2025
(/) Earnings [ ₹38.6 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 22.48x ]
Thus, for KOPRAN , the investors are currently willing to pay 22.48 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of KOPRAN !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of KOPRAN over the last five years.
Historical PE (Price/Earnings) ratio chart of KOPRAN
PE Ratio Performance Analysis for KOPRAN
- KOPRAN 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 15.77x.
- KOPRAN 's operated at median p/e ratio of 19.55x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, KOPRAN 's p/e ratio peaked in Mar2024 at 24.45x.
- KOPRAN 's p/e ratio hit its five-year low in Mar2020 of 5.22x.
How does KOPRAN 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
KOPRAN | 38.55 | 22.48 | 866.5 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,980.10 | 37.75 | 414,533.0 |
DIVIS LABORATORIES LTD | 2,191.00 | 82.25 | 180,215.0 |
CIPLA LTD | 5,291.05 | 22.76 | 120,428.0 |
TORRENT PHARMACEUTICALS LTD | 1,911.00 | 60.92 | 116,410.0 |
DR REDDYS LABORATORIES LTD | 5,703.50 | 18.45 | 105,253.0 |
MANKIND PHARMA LTD | 2,003.22 | 54.64 | 109,464.0 |
ZYDUS LIFESCIENCES LTD | 4,614.80 | 21.09 | 97,317.9 |
LUPIN LTD | 3,306.26 | 26.96 | 89,121.3 |
AUROBINDO PHARMA LTD | 3,515.26 | 19.03 | 66,911.2 |
ABBOTT INDIA LTD | 1,414.44 | 51.57 | 72,938.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs KOPRAN 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 18.45x |
Max industry PE | 82.25x |
Median industry PE | 26.96x |
Average industry PE | 37.99x |
You may also like the below Video Courses